SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (2987)5/25/1999 9:36:00 PM
From: LLCF  Read Replies (2) of 10280
 
< At what point will you exit ? >

When the story changes or stock becomes overvalued... price matters not without a change in the story (except you buy on the way down). If this new drug that is causing the tizzy (IMO) can get to market in time to damage SEPR, assess the damage (take future assumed revenues from antihistamines out of the model????) and re-evaluate.

<Certainly,without news one cannot expect a sustained rebound,>

Actually I believe the opposite... once people have evaluated the long term effect of the Anti-IgE part of the equation the stock will move to it's proper level... it could grind up for months if IgE is no big deal... the panick will subside. If IgE news is still considered dire when the dust settles, the stock will find it's level based on the new valuation model. IgE drives the stock IMO (for now).

< in this market where even companies with solid earning got smashed (PFE etc)>

Actually on a valuation basis PFE's earnings while solid are certainly "light"... lots of growth built in there! It looks to me like people are selling whatever they have large profits in... from QCOM, .COM, to SEPR.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext